More than half of all new type 1 diabetes cases actually occur in adulthood, not childhood. Late-onset type 1 diabetes is driven by the same core process as the childhood form: the immune system mistakenly attacks the insulin-producing cells in the pancreas. But in adults, that destruction happens more slowly, the symptoms look different, and a combination of genetics, viral exposures, and gut health helps explain why the disease can stay hidden for decades before surfacing.
Why the Immune Attack Starts
Type 1 diabetes is an autoimmune disease. Your immune system produces antibodies that target the beta cells in your pancreas, the only cells that make insulin. In children, this attack is fast and aggressive, often wiping out beta cell function within months. In adults, the destruction unfolds over years, sometimes a decade or more. C-peptide levels, a measure of how much insulin your pancreas still produces, decline much more gradually than in childhood-onset cases. This slow burn is the hallmark of late-onset type 1 diabetes, and it’s the main reason the condition is so frequently mistaken for type 2.
The autoimmune process leaves a fingerprint: specific antibodies circulating in the blood. Antibodies against an enzyme called GAD-65 are found in about 80% of people with type 1 diabetes at the time of diagnosis. In children, insulin autoantibodies are typically the first to appear and are present in roughly 70% of young children at diagnosis. In adults, GAD antibodies tend to dominate, and they can be detectable years before blood sugar levels rise enough to cause symptoms.
The Genetic Blueprint
Your genes don’t cause late-onset type 1 diabetes on their own, but they set the stage. The most important genetic factor is a cluster of immune-system genes known as the HLA region, specifically the DR and DQ gene variants. Certain combinations, particularly DR3/DR4, carry the highest risk. People with DR3/DR4 are more likely to develop type 1 diabetes in childhood, while those carrying only one of these risk variants, or lower-risk combinations, tend to develop the disease later in life.
A large meta-analysis across multiple populations confirmed that the DR-DQ genotype is the single strongest genetic predictor of when type 1 diabetes appears. Two additional gene variants, called A*24:02 and B*39:06, also significantly influence the age of onset. On the protective side, carrying the DQB1*06:02 variant substantially lowers risk. In practical terms, adults who develop type 1 diabetes typically carry fewer high-risk gene variants than children who develop it, which helps explain why their immune attack builds more slowly and why they may not show symptoms until their 30s, 40s, or later.
Viral Triggers and Environmental Exposure
Genetics loads the gun, but something in the environment pulls the trigger. Enteroviruses, a large family of common viruses that includes coxsackievirus B, are the strongest candidates. A meta-analysis of studies through 2010 found a clinically significant link between enterovirus infection and the development of beta cell autoimmunity. The TEDDY study, one of the largest prospective studies on the topic, confirmed that a specific subgroup of enteroviruses (EV-B) was associated with the onset of autoimmunity in genetically susceptible children.
The type of infection matters. Prolonged infections, where the same virus was detected in stool samples over several months, were strongly tied to the start of autoimmunity. Brief infections that cleared quickly were not. This suggests that a lingering viral presence in the gut may be what tips the immune system into attacking the pancreas. Research has also found that enterovirus infections during pregnancy can increase the risk of autoimmunity in the child, particularly in mothers who carry high-risk HLA gene variants.
For adults, the implication is that a viral infection at any point in life could initiate or accelerate the autoimmune process, especially in someone already carrying genetic risk factors. Because the immune attack progresses slowly, the triggering event may have occurred years or even decades before diagnosis.
The Role of Gut Health
The gut microbiome, the trillions of bacteria living in your digestive tract, plays a surprisingly central role. People with type 1 diabetes consistently show a pattern called dysbiosis: an overgrowth of certain inflammatory bacteria and a shortage of protective ones. Specifically, studies find higher levels of Bacteroidetes bacteria and lower levels of Firmicutes. Bacteroides species, which are linked to gut inflammation and increased intestinal permeability, are elevated, while Prevotella species, which appear protective, are depleted.
Bifidobacteria, another beneficial group, are also reduced in people with beta cell autoimmunity. These bacteria help produce short-chain fatty acids, compounds that nourish the gut lining and keep it intact. When that lining breaks down, a condition sometimes called “leaky gut,” immune-triggering molecules can pass through and potentially set off or worsen the autoimmune response against the pancreas. Studies have found increased intestinal permeability in people at risk for type 1 diabetes, and this permeability correlates with the microbiome changes described above. In animal models of autoimmune diabetes, gut barrier problems and shifts in bacterial populations appear before the immune system even begins attacking the pancreas.
How Obesity Complicates the Picture
Rising rates of overweight and obesity are adding another layer of complexity. Research has explored the relationship between increasing body mass during late adolescence and the development of type 1 diabetes in young adulthood. Excess weight creates insulin resistance, which forces remaining beta cells to work harder. In someone whose beta cells are already under autoimmune attack, this extra demand can accelerate the point at which the pancreas can no longer keep up, pushing symptoms to the surface sooner.
There is also growing recognition of “double diabetes” or “hybrid diabetes,” where features of both type 1 and type 2 coexist in the same person. An adult who is overweight and develops autoimmune diabetes may have both insulin resistance and an immune-mediated loss of beta cells. This combination raises the risk of cardiovascular disease, abnormal cholesterol levels, and other complications beyond what either type alone would produce.
Why It Gets Misdiagnosed So Often
Between 4% and 12% of adults initially told they have type 2 diabetes actually have late-onset type 1, often classified as latent autoimmune diabetes in adults (LADA). The confusion is understandable: these patients are adults, they may be overweight, and their blood sugar rises gradually rather than crashing into a crisis. Doctors may reasonably start with a type 2 diagnosis and prescribe oral medications.
The problem is that those medications treat insulin resistance, not a failing pancreas. Over months or years, patients with misdiagnosed LADA find that their blood sugar becomes harder and harder to control. They eventually need insulin, but the delay can mean prolonged periods of poor blood sugar management.
Two tests help distinguish the conditions. A C-peptide test measures how much insulin the pancreas is producing. In a study comparing LADA patients with matched type 2 patients, the average C-peptide level in the LADA group was 1.0 ng/mL compared to 5.1 ng/mL in the type 2 group. An elevated C-peptide level effectively rules out LADA. If the C-peptide comes back low or normal, testing for GAD antibodies can confirm the autoimmune nature of the disease. This two-step approach, C-peptide first, then antibody testing if needed, is the most practical path to an accurate diagnosis.
Who Should Be Suspicious
Certain patterns raise the likelihood that an adult’s diabetes is actually autoimmune. People diagnosed with type 2 diabetes who are lean or only mildly overweight, who don’t have a strong family history of type 2, or who find that standard oral medications stop working within a few years should consider further testing. A personal or family history of other autoimmune conditions, such as thyroid disease or celiac disease, also increases the odds. The onset is typically between ages 30 and 50, though it can occur later. Unlike the dramatic thirst, weight loss, and frequent urination that often mark childhood type 1 diabetes, the symptoms in adults may be subtle at first, becoming unmistakable only after a significant portion of beta cell function has already been lost.